🎯 check Romidepsin (FK228) product page
Romidepsin (FK228) is a potent, selective class I HDAC inhibitor. It affects PI3K/AKT, MAPK, and NF-κB signaling pathways, and by increasing histone acetylation and altering gene expression, it inhibits tumor cell proliferation and promotes apoptosis.